Primary Record
Bortezomib
- In stock
- 3,148 g
- Purity
- 98.7 %
- CAS
- 179324-69-7
Compound Identifiers & Properties
- CAS
- 179324-69-7
- PubChem CID
- 387447
- SMILES
- B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
- Canonical SMILES
- CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O
Names & Synonyms
- Bortezomib
- Velcade
- 179324-69-7
- radiciol
- PS-341
- Bortezomib (PS-341)
- bortezomibum
- Bortexomib
- Zindoxifene
- Bortezomib accord
- Pyz-Phe-boroLeu
- Peptide boronate
- Velcade (TN)
- Bortezomib hydrate
- LDP-341
- Bortezomib,Velcade
- DPBA
- Bortezomib (Velcade)
- Bortezomib [USAN]
- Velcade (Millenium)
- BORUZU
- Ps 341
- Bortezomib (Standard)
- RefChem:5614
- 3mg0
- BORTEZOMIB [MI]
- Bortezomib for Injection
- PS 341 (pharmaceutical)
- C19H25BN4O4
- AC1L8TUW
- BORTEZOMIB [INN]
- BORTEZOMIB [JAN]
- Bortezomib [USAN:INN]
- LDP 341
- MLN-341
- 69G8BD63PP
- BORTEZOMIB [HSDB]
- PS-341 [Bortezomib]
- PS-341[pharmaceutical]
- UNII-69G8BD63PP
- Boronic acid, L-(S)-
- NSC-681239
- PROSCRIPT BORONIC ACID
- BORTEZOMIB [VANDF]
- DTXSID3040980
- MFCD09056737
- cc-75
- D0SH3I
- Bortezomib [USAN:INN:BAN]
- BORTEZOMIB [MART.]
- LPD-341
- CHEMBL325041
- LDP341
- BORTEZOMIB [WHO-DD]
- Bortezomib(JAN/USAN/INN)
- MG-341
- DTXCID1020980
- CHEBI:52717
- HSDB 7666
- MLS004774142
- Bortezomib (JAN/USAN/INN)
- BORTEZOMIB [EMA EPAR]
- SCHEMBL192129
- LPD 341
- GXJABQQUPOEUTA-RDJZCZTQSA-N
- Bortezomib - Bio-X trade mark
- GTPL6391
- orb1305542
- PS341
- Peptidyl boronic acid derivative
- Bortezomib (Mixture of isomers)
- BORTEZOMIB [ORANGE BOOK]
- BORTEZOMIB HYDRATE [JAN]
- SCHEMBL29377226
- CTK8B8979
- AOB6368
- Bortezomib (Proteasome inhibitor)
- L01XX32
- Dipeptidyl boronic acid derivative
- MG 341
- NSC681239
- GLXC-05159
- NSC 681239
- 341, PS
- EX-A8373
- Bortezomib, 98% - 25MG 25mg
- Tox21_112630
- Tox21_112672
- ((R)-3-Methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid
- ABP000234
- ANW-61718
- BBF-05860
- BDBM50069989
- C19-H25-B-N4-O4
- CB0261
- CID387447
- EBC-11290
- HB4036
- HY-10227R
- MFCD27978443
- NCGC00242506-02
- NSC756655
- AKOS015909706
- Tox21_112672_1
- ZINC169746649
- [(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid
- ACN-030054
- AM81235
- CCG-268449
- CID:387447
- CS-1039
- CS-O-00482
- DB00188
- FM19000
- MG-341; PS-341
- NSC-756655
- RL02288
- Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-
- Bortezomib/Velcade, MG-341, PS-341
- NCGC00168751-01
- NCGC00181022-01
- NCGC00242506-01
- NCGC00242506-06
- NCGC00242506-07
- S1013
- AS-15721
- BB164258
- BC201423
- HY-10227
- NCI60_029010
- Q425
- SC-23571
- SMR003500787
- SY008095
- Bortezomib (Velcade,MG-341,PS-341)?
- SID:283537489
- Velcade, MG-341, PS-341, Bortezomib
- AB0017579
- AB2000734
- RT-000308
- ST2406732
- A2614
- B5741
- CAS-179324-69-7
- N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE
- NS00006197
- SW208077-3
- J1.921.292K
- KS-00000761
- [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid
- A10160
- A18332
- D03150
- EN300-657180
- Q-4365
- AB01273951-01
- AB01273951-02
- AB01273951_03
- 324B697
- C400082
- Q419319
- SR-01000939863
- I14-3268
- SR-01000939863-2
- BRD-K88510285-001-02-0
- BRD-K88510285-001-11-1
- BRD-K88510285-001-17-8
- BRD-K88510285-001-18-6
- Velcade, MG-341, PS-341,179324-69-7
- D000069286
- Z2213886907
- [(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid
- [(1R)-3-METHYL-1-[[(2S)-1-OXO-3-PHENYL-2-[(PYRAZINYLCARBONYL)AMINO]PROPYL]AMINO]BUTYL]-BORONIC ACID
- Boronic acid, ((1R)-3-methyl-1-(((2S)-1-oxo-3-phenyl-2-((pyrazinylcarbonyl)amino)propyl)amino)butyl)-
- N-((1S)-1-Benzyl-2-(((1R)-1-(dihydroxyboranyl)-3-methylbutyl)amino)-2-oxoethyl)pyrazinecarboxamide
- n-(2-pyrazine)carbonyl-l-phenylalanine-l-leucine boronic acid
- (R)-3-methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butylboronic acid
- [(1R)-3-methyl-1-[(2S)-3-phenyl-2-[(pyrazin-2-yl)formamido]propanamido]butyl]boronic acid
- N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide
- ((1R)-3-Methyl-1-(((2S)-3-phenyl-2-((pyrazinylcarbonyl)amino)propanoyl)amino)butyl)boronic acid
- BO2
- ((1R)-3-methyl-1-((2S)-3-phenyl-2-(pyrazin-2-ylformamido)propanamido)butyl)boronic acid
- ((R)-3-methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronicacid
- (R)-3-methyl-1-((S)-3-phenyl-2-(pyrazine-6-carboxamido)propanamido)butylboronic acid
- N-((1R)-1-(DIHYDROXYBORYL)-3-methylbutyl)-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide
- N-[(1R)-1-Borono-3-methylbutyl]-Nalpha-(pyrazine-2-carbonyl)-L-phenylalaninamide
- ((1R)-3-methyl-1-(((2S)-3-phenyl-2-((pyrazin-2-ylcarbonyl)amino)propanoyl)amino)butyl)boronic acid
- (1R)-3-Methyl-1-({(2S)-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propanoyl}amino)butylboronic acid, AldrichCPR
- (2S)-N-((1R)-1-Dihydroxyboryl-3-methylbutane-1-yl)-2-(2-pyrazinylcarbonylamino)-3-phenylpropanamide
- (R)-3-METHYL-1-((S)-3-PHENYL-2-(PYRAZINE-2-CARBOXAMIDO)PROPANAMIDO)BUTAN-2-YLBORONIC ACID
- [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid
- [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]-butyl]boronic acid
- [(1R)-3-Methyl-1-[[(2S)-3-phenyl-2-[(pyrazinylcarbonyl)amino]propanoyl]amino]butyl]boronic acid
- 1610526-91-4
- Boronic acid, (3-methyl-1-((1-oxo-3-phenyl-2-((pyrazinylcarbonyl)amino)propyl)amino)butyl)-, (S-(R*,S*))-
- Boronic acid, [(1(R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-
- Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-; Boronic acid, [(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]- (9CI); Boronic acid, [3-methyl-1-[[1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-, [S-(R*,S*)]-; Bortezomib; DPBA; LDP 341; MG 341; MLN 341; NSC 681239; PS 314; PS 341; PS 341 (pharmaceutical); Radiciol; Velcade
- Boronic acid,B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-
- BTZ
- N-((1S)-1-benzyl-2-(((1R)-1-(dihydroxyboranyl)-3-methylbutyl)amino)2-oxoethylpyrazinecarboxamide
- N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-N(alpha)-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide